Hyperghrelinemia Is a Common Feature of Prader-Willi Syndrome and Pituitary Stalk Interruption: A Pathophysiological Hypothesis
- 1 July 2004
- journal article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 62 (1), 49-54
- https://doi.org/10.1159/000078862
Abstract
Background: Elevated plasma ghrelin levels have recently been reported in adults and children with Prader-Willi syndrome (PWS). The aim of the study is to investigate the relationship between obesity, growth hormone (GH) deficiency (GHD) and ghrelinemia in PWS and to examine whether hyperghrelinemia is specific to PWS. Methods: We measured fasting ghrelinemia in children with PWS, idiopathic GHD (iGHD), obese children, controls and in 6 children presenting another congenital syndrome associated with GHD: pituitary stalk interruption (PSI). Results: Children with PWS exhibited significantly higher ghrelin levels (995 pg/ml (801/1,099, median 1st/3rd quartile)) than iGHD (517 pg/ml (392/775)), obese (396 pg/ml (145/610)) and control (605 ng/ml (413/753)) children. Similar to PWS hyperghrelinemia was found in PSI children (1,029 pg/ml (705/1,151)), and was not modified by GH treatment. Conclusion: We conclude that hyperghrelinemia in PWS and PSI is not related to GH secretion. We hypothesize that a major site of ghrelin action is at the hypothalamic level and that a ‘ghrelin resistance’ syndrome may be present in these patients, primarily due to a hypothalamic defect. Combined alterations such as impaired serotonin receptor regulation associated with abnormal ghrelin responsiveness are probably responsible for obesity in PWS.Keywords
This publication has 14 references indexed in Scilit:
- Ghrelin Main Action on the Regulation of Growth Hormone Release Is Exerted at Hypothalamic LevelJournal of Clinical Endocrinology & Metabolism, 2003
- Agouti-Related Peptide, Neuropeptide Y, and Somatostatin-Producing Neurons Are Targets for Ghrelin Actions in the Rat HypothalamusEndocrinology, 2003
- Serum Ghrelin Levels Are Inversely Correlated with Body Mass Index, Age, and Insulin Concentrations in Normal Children and Are Markedly Increased in Prader-Willi SyndromeJournal of Clinical Endocrinology & Metabolism, 2003
- The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in ratsGastroenterology, 2002
- Elevated plasma ghrelin levels in Prader–Willi syndromeNature Medicine, 2002
- Ghrelin: The Link Connecting Growth with Metabolism and Energy HomeostasisReviews in Endocrine and Metabolic Disorders, 2002
- Genome Organization, Function, and Imprinting in Prader-Willi and Angelman SyndromesAnnual Review of Genomics and Human Genetics, 2001
- Endocrine Activities of Ghrelin, a Natural Growth Hormone Secretagogue (GHS), in Humans: Comparison and Interactions with Hexarelin, a Nonnatural Peptidyl GHS, and GH-Releasing HormoneJournal of Clinical Endocrinology & Metabolism, 2001
- Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organizationProceedings of the National Academy of Sciences, 2000
- Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP- 6 main action is exerted at the hypothalamic levelJournal of Clinical Endocrinology & Metabolism, 1995